Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...